Replies to post #118874 on Anavex Life Sciences Corp (AVXL)

[NWDR]

I agree. I would think 12 weeks would show a significant improvement in AZ patients on an optimized does of A2-73 PLUS vs. placebo vs. Aricept. My guess at a timeline is something like;

Sept / Oct - Anavex announces partnership for AZ
Nov / Dec - AZ trial starts
Mar / Apr - AZ trial fully enrolled
Jun / Jul - first interim analysis, all patients
Aug / Sept - trial halted, all patients switched to plus
1Q 2019 - approval to market A2-73 Plus

I would really like this to be earlier for a variety of reasons but I'm trying to be realistic with how slow the FDA moves and how much work there actually is to do in collecting, analyzing, filling out paperwork, etc..

Sometime next summer, if the trial is halted for efficacy then some of the optimistic market cap projections will start to be met.

Go AVXL